Login Register Cart 0
Research Article

MicroRNA Levels in Cervical Cancer Samples and Relationship with Lesion Grade and HPV Infection

Author(s): Carolina R. Hoelzle, Solène Arnoult, Cinthya R.M. Borém, Mariana Ottone, Kênia C.S.F. de Magalhães, Istéfani L. da Silva* and Renata T. Simões

Volume 10, Issue 2, 2021

Published on: 04 June, 2021

Page: [139 - 145] Pages: 7

DOI: 10.2174/2211536610666210604123534

Price: $65

Open Access Journals Promotions 2
Abstract

Background: miR-21, miR-214 and miR-let-7a are three validated and well-known miRNAs. miR-21 is described as an “oncomir” while miR-214 and miR-let-7a are described mainly as tumor suppressors. The role of these miRNAs remains unclear in cervical cancer, an important malignancy among women worldwide and responsible for many deaths every year.

Objective: The objective of this study is to describe the expression profile of miR-21, miR-214 and miR-let-7a in plasma and in cervical scraping from a control group and patients with different grades of cervical lesions and invasive cervical cancer and correlate with HPV infection groups.

Methods: Plasma and cervical scraping were submitted to DNA and RNA extraction. HPV detection and typing were performed by conventional PCR followed by PAGE to amplicons interpretation. The miRNA relative expression in plasma and cervical scraping samples was performed by real time PCR using specific TaqMan probes.

Results: miR-21 (p=0.0277) and miR-214 (p=0.0151) were up-regulated in cervical scraping samples of invasive cervical cancer (ICC) group. However, miR-214 was also up-regulated in the LSIL group (p=0.0062). Both miRNAs were not related to HPV infection. However, miR-let-7a was higher in HPV positive plasma samples (p=0.0433) than in HPV negative plasma samples and the correlation analysis confirmed the association between the levels of this miRNA with the presence of HPV (p=0.0407; r=0.3029), but not with lesion grade (p>0.05).

Conclusion: Our results suggest that miR-21 is related to cervical cancer progression and miR-214 appears to have an ambiguous role in cervical lesions. miR-let-7a may be upregulated at a systemic level in patients with HPV infection.

Keywords: Oncomir, circulating miRNAs, miR-21, miR-let-7a, miR-214, human papilloma virus.

« Previous Next »
Graphical Abstract

[1]
Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281-97.
[http://dx.doi.org/10.1016/S0092-8674(04)00045-5] [PMID: 14744438]
[2]
Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136(2): 215-33.
[http://dx.doi.org/10.1016/j.cell.2009.01.002] [PMID: 19167326]
[3]
Essandoh K, Li Y, Huo J, Fan GC. MiRNA-mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock 2016; 46(2): 122-31.
[http://dx.doi.org/10.1097/SHK.0000000000000604] [PMID: 26954942]
[4]
Sanjay S, Girish C. Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury. Eur J Clin Pharmacol 2017; 73(4): 399-407.
[http://dx.doi.org/10.1007/s00228-016-2183-1] [PMID: 28028586]
[5]
Athanasopoulos D, Karagiannis G, Tsolaki M. Recent findings in Alzheimer disease and nutrition focusing on epigenetics. Adv Nutr 2016; 7(5): 917-27.
[http://dx.doi.org/10.3945/an.116.012229] [PMID: 27633107]
[6]
Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol 2016; 98: 12-23.
[http://dx.doi.org/10.1016/j.critrevonc.2015.10.003] [PMID: 26481951]
[7]
Andersen GB, Tost J. Circulating miRNAs as biomarker in cancer. Recent Results Cancer Res 2020; 215: 277-98.
[http://dx.doi.org/10.1007/978-3-030-26439-0_15] [PMID: 31605235]
[8]
Michael Traeger M, Rehkaemper J, Ullerich H, et al. The ambiguous role of microRNA-205 and its clinical potential in pancreatic ductal adenocarcinoma. J Cancer Res Clin Oncol 2018; 144(12): 2419-31.
[http://dx.doi.org/10.1007/s00432-018-2755-9] [PMID: 30244390]
[9]
Pardini B, De Maria D, Francavilla A, Di Gaetano C, Ronco G, Naccarati A. MicroRNAs as markers of progression in cervical cancer: A systematic review. BMC Cancer 2018; 18(1): 696.
[http://dx.doi.org/10.1186/s12885-018-4590-4] [PMID: 29945565]
[10]
Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer 2018; 42(5): 457-65.
[http://dx.doi.org/10.1016/j.currproblcancer.2018.06.003] [PMID: 30064936]
[11]
zur Hausen H. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2(5): 342-50.
[http://dx.doi.org/10.1038/nrc798] [PMID: 12044010]
[12]
Pedroza-Torres A, López-Urrutia E, García-Castillo V, et al. MicroRNAs in cervical cancer: Evidences for a miRNA profile deregulated by HPV and its impact on radio-resistance. Molecules 2014; 19(5): 6263-81.
[http://dx.doi.org/10.3390/molecules19056263] [PMID: 24840898]
[13]
Harden ME, Munger K. Human papillomavirus 16 E6 and E7 oncoprotein expression alters microRNA expression in extracellular vesicles. Virology 2017; 508: 63-9.
[http://dx.doi.org/10.1016/j.virol.2017.05.005] [PMID: 28500882]
[14]
Wang H, Zhang D, Chen Q, Hong Y. Plasma expression of miRNA-21, - 214, -34a, and -200a in patients with persistent HPV infection and cervical lesions. BMC Cancer 2019; 19(1): 986.
[http://dx.doi.org/10.1186/s12885-019-6066-6] [PMID: 31646977]
[15]
Park S, Eom K, Kim J, et al. MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer. BMC Cancer 2017; 17(1): 658.
[http://dx.doi.org/10.1186/s12885-017-3642-5] [PMID: 28934937]
[16]
Emami SS, Nekouian R, Akbari A, Faraji A, Abbasi V, Agah S. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer. J Cancer Res Ther 2019; 15(1): 115-9.
[PMID: 30880765]
[17]
Campayo M, Navarro A, Benítez JC, et al. MiR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer. PLoS One 2018; 13(11): e0206542.
[http://dx.doi.org/10.1371/journal.pone.0206542] [PMID: 30388154]
[18]
Dai L, Chen F, Zheng Y, et al. MiR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling. Front Biosci 2019; 24: 1426-39.
[http://dx.doi.org/10.2741/4788] [PMID: 31136988]
[19]
Wang JM, Ju BH, Pan CJ, et al. MiR-214 inhibits cell migration, invasion and promotes the drug sensitivity in human cervical cancer by targeting FOXM1. Am J Transl Res 2017; 9(8): 3541-57.
[PMID: 28861147]
[20]
Wang F, Tan WH, Liu W, et al. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway. Eur Rev Med Pharmacol Sci 2018; 22(7): 1891-8.
[PMID: 29687840]
[21]
Moss EG, Lee RC, Ambros V. The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA. Cell 1997; 88(5): 637-46.
[http://dx.doi.org/10.1016/S0092-8674(00)81906-6] [PMID: 9054503]
[22]
Balzeau J, Menezes MR, Cao S, Hagan JP. The LIN28/let-7 pathway in cancer. Front Genet 2017; 8: 31.
[http://dx.doi.org/10.3389/fgene.2017.00031] [PMID: 28400788]
[23]
Ribeiro J, Marinho-Dias J, Monteiro P, et al. MiR-34a and miR-125b expression in HPV infection and cervical cancer development. BioMed Res Int 2015; 2015: 304584.
[http://dx.doi.org/10.1155/2015/304584] [PMID: 26180794]
[24]
Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 1990; 71(1): 173-81.
[http://dx.doi.org/10.1099/0022-1317-71-1-173] [PMID: 2154534]
[25]
de Roda Husman AM, Snijders PJ, Stel HV, van den Brule AJ, Meijer CJ, Walboomers JM. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995; 72(2): 412-7.
[http://dx.doi.org/10.1038/bjc.1995.347] [PMID: 7543772]
[26]
van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 1990; 28(12): 2739-43.
[http://dx.doi.org/10.1128/JCM.28.12.2739-2743.1990] [PMID: 2177751]
[27]
Sanguinetti CJ, Dias Neto E, Simpson AJ. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994; 17(5): 914-21.
[PMID: 7840973]
[28]
Silva ID, Muniz YC, Sousa MC, et al. HLA-G 3'UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum Immunol 2013; 74(4): 452-8.
[http://dx.doi.org/10.1016/j.humimm.2012.11.025] [PMID: 23228396]
[29]
Bautista-Sánchez D, Arriaga-Canon C, Pedroza-Torres A, et al. The promising role of miR-21 as a cancer biomarker and its importance in RNA-based therapeutics. Mol Ther Nucleic Acids 2020; 20: 409-20.
[http://dx.doi.org/10.1016/j.omtn.2020.03.003] [PMID: 32244168]
[30]
Sheedy FJ. Turning 21: Induction of miR-21 as a key switch in the inflammatory response. Front Immunol 2015; 6: 19.
[http://dx.doi.org/10.3389/fimmu.2015.00019] [PMID: 25688245]
[31]
Song L, Liu S, Zhang L, et al. MiR-21 modulates radiosensitivity of cervical cancer through inhibiting autophagy via the PTEN/Akt/HIF-1α feedback loop and the Akt-mTOR signaling pathway. Tumour Biol 2016; 37(9): 12161-8.
[http://dx.doi.org/10.1007/s13277-016-5073-3] [PMID: 27220494]
[32]
Zhang Z, Wang J, Wang X, Song W, Shi Y, Zhang L. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3. Arch Gynecol Obstet 2018; 297(2): 433-42.
[http://dx.doi.org/10.1007/s00404-017-4598-z] [PMID: 29177591]
[33]
Yuan Y, Min SJ, Xu DQ, et al. Expressions of VEGF and miR-21 in tumor tissues of cervical cancer patients with HPV infection and their relationships with prognosis. Eur Rev Med Pharmacol Sci 2018; 22(19): 6274-9.
[PMID: 30338794]
[34]
Bumrungthai S, Ekalaksananan T, Evans MF, et al. Up-regulation of miR-21 is associated with cervicitis and human Papillomavirus infection in cervical tissues. PLoS One 2015; 10(5): e0127109.
[http://dx.doi.org/10.1371/journal.pone.0127109] [PMID: 26010154]
[35]
Orso F, Quirico L, Virga F, et al. MiR-214 and miR-148b targeting inhibits dissemination of melanoma and breast cancer. Cancer Res 2016; 76(17): 5151-62.
[http://dx.doi.org/10.1158/0008-5472.CAN-15-1322] [PMID: 27328731]
[36]
Yang Y, Li Z, Yuan H, et al. Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer. Oncogenesis 2019; 8(9): 50.
[http://dx.doi.org/10.1038/s41389-019-0151-1] [PMID: 31492847]
[37]
Peng R, Men J, Ma R, et al. MiR-214 down-regulates ARL2 and suppresses growth and invasion of cervical cancer cells. Biochem Biophys Res Commun 2017; 484(3): 623-30.
[http://dx.doi.org/10.1016/j.bbrc.2017.01.152] [PMID: 28137590]
[38]
Bennett PE, Bemis L, Norris DA, Shellman YG. MiR in melanoma development: MiRNAs and acquired hallmarks of cancer in melanoma. Physiol Genomics 2013; 45(22): 1049-59.
[http://dx.doi.org/10.1152/physiolgenomics.00116.2013] [PMID: 24046283]
[39]
Penna E, Orso F, Cimino D, et al. MicroRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011; 30(10): 1990-2007.
[http://dx.doi.org/10.1038/emboj.2011.102] [PMID: 21468029]
[40]
Li HL, Liang S, Cui JH, Han GY. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis. Eur Rev Med Pharmacol Sci 2018; 22(1): 127-34.
[PMID: 29364479]
[41]
Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000; 403(6772): 901-6.
[http://dx.doi.org/10.1038/35002607] [PMID: 10706289]
[42]
Yang N, Kaur S, Volinia S, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008; 68(24): 10307-14.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-1954] [PMID: 19074899]
[43]
Zhao Y, Deng C, Lu W, et al. let-7 MicroRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer. Mol Med 2011; 17(11-12): 1233-41.
[http://dx.doi.org/10.2119/molmed.2010.00225] [PMID: 21826373]
[44]
Wang T, Wang G, Hao D, et al. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer. Mol Cancer 2015; 14: 125.
[http://dx.doi.org/10.1186/s12943-015-0402-5] [PMID: 26123544]
[45]
Perdas E, Stawski R, Nowak D, Zubrzycka M. The role of miRNA in papillary thyroid cancer in the context of miRNA let-7 family. Int J Mol Sci 2016; 17(6): E909.
[http://dx.doi.org/10.3390/ijms17060909] [PMID: 27314338]
[46]
Geng L, Zhu B, Dai BH, et al. A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis. Biochem Biophys Res Commun 2011; 408(3): 494-9.
[http://dx.doi.org/10.1016/j.bbrc.2011.04.074] [PMID: 21530489]
[47]
Honegger A, Schilling D, Bastian S, et al. Dependence of intracellular and exosomal microRNAs on viral E6/E7 oncogene expression in HPV-positive tumor cells. PLoS Pathog 2015; 11(3): e1004712.
[http://dx.doi.org/10.1371/journal.ppat.1004712] [PMID: 25760330]
[48]
Zamora-Contreras AM, Alvarez-Salas LM. Let-7 miRNA precursors co-express with LIN28B in cervical cells. MicroRNA 2018; 7(1): 62-71.
[http://dx.doi.org/10.2174/2211536607666180115143014] [PMID: 29336272]
[49]
Zamani S, Sohrabi A, Hosseini SM, Rahnamaye-Farzami M, Akbari A. Deregulation of miR-21 and miR-29a in cervical cancer related to HPV infection. MicroRNA 2019; 8(2): 110-5.
[http://dx.doi.org/10.2174/2211536607666181017124349] [PMID: 30332981]
[50]
Zamani S, Hosseini SM, Sohrabi A. MiR-21 and miR29-a: Potential molecular biomarkers for HPV genotypes and cervical cancer detection. MicroRNA 2020; 9(4): 271-5.
[http://dx.doi.org/10.2174/2211536609666191115110015] [PMID: 31733640]
[51]
Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P, Kiss I. MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res 2015; 35(1): 523-30.
[PMID: 25550598]

Rights & Permissions Print Cite
Article Metrics
28
1
Wayfinder Image
Open Access Journals Promotions
© 2024 Bentham Science Publishers | Privacy Policy